These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 39279951)
1. The benefit of adjuvant chemotherapy in pathological T1-3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data. Liao H; Zeng T; Xie X; Li J; Li D; Yan K; Chen F; Zhu H J Gastrointest Oncol; 2024 Aug; 15(4):1568-1579. PubMed ID: 39279951 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population]. Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data. Liao H; Zeng T; Xie X; Li J; Li D; KejinYan ; Chen F; Zhu H Int J Colorectal Dis; 2023 May; 38(1):134. PubMed ID: 37199862 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy improves long-term survival in pathologic stage III rectal mucinous adenocarcinoma after pre-operative chemoradiotherapy. Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T Int J Colorectal Dis; 2023 Aug; 38(1):207. PubMed ID: 37542591 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant Radiotherapy Is Not Necessary for Stage III Mucinous Rectal Cancer: Evidence Based on Long Survival Analysis from SEER Data. Liao H; Tang C; Zhou Z; Shi H; Li T; Liang Y; Li M; Li T; Lei X J Gastrointest Surg; 2023 Dec; 27(12):2857-2866. PubMed ID: 37989932 [TBL] [Abstract][Full Text] [Related]
6. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114 [TBL] [Abstract][Full Text] [Related]
7. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study. Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients. Tarantino I; Hüttner FJ; Warschkow R; Schmied BM; Diener MK; Ulrich A Ann Surg Oncol; 2016 May; 23(5):1576-86. PubMed ID: 26714956 [TBL] [Abstract][Full Text] [Related]
9. Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study. Yang WW; Fang YT; Niu YR; Sun YK World J Gastrointest Oncol; 2023 Aug; 15(8):1436-1450. PubMed ID: 37663946 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis. Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444 [TBL] [Abstract][Full Text] [Related]
11. Survival benefit of perioperative chemotherapy for T1-3N0M0 stage esophageal cancer: a SEER database analysis. Shao Y; Chen D; Ye L; Wang XM; Wu QC; Zhang C J Thorac Dis; 2021 Feb; 13(2):995-1004. PubMed ID: 33717572 [TBL] [Abstract][Full Text] [Related]
12. Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study. Zhao F; Yu X; Xu M; Ye S; Zang S; Zhong W; Ren G; Chen X; Yan S Front Oncol; 2019; 9():1467. PubMed ID: 31998638 [No Abstract] [Full Text] [Related]
13. Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery. Liang Y; Liao H; Shi H; Li T; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T Front Oncol; 2024; 14():1352660. PubMed ID: 38511138 [TBL] [Abstract][Full Text] [Related]
14. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. Evers PD; Logan JE; Sills V; Chin AI World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991 [TBL] [Abstract][Full Text] [Related]
15. Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis. Widmann B; Warschkow R; Schmied BM; Marti L; Steffen T J Gastrointest Surg; 2016 Aug; 20(8):1493-502. PubMed ID: 27120448 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis. Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum. Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study. Lee KC; Chung KC; Chen HH; Liu CC; Lu CC J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257 [TBL] [Abstract][Full Text] [Related]
19. The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis. Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T Int J Colorectal Dis; 2023 Sep; 38(1):235. PubMed ID: 37725159 [TBL] [Abstract][Full Text] [Related]
20. Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma. Cao BY; Wang QQ; Zhang LT; Wu CC; Tong F; Yang W; Wang J World J Gastrointest Oncol; 2023 Jan; 15(1):155-170. PubMed ID: 36684051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]